Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin.
Evelyn KrohmerBrit Silja RohrFelicitas StollKatja S GümüsMariano BergaminoGerd MikusMax SauterJuergen BurhenneJohanna WeissAndreas Daniel MeidDavid CzockAntje BlankWalter Emil HaefeliPublished in: Cardiovascular drugs and therapy (2023)
EudraCT number: 2021-006634-39. DRKS00027838.